Doctor profile · Federal record
Dr. Utpal Pajvani, MD, PHD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · New York, NY
- NPI 1922257773
- Accepts Medicare
- MIPS 93.4 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1150 Saint Nicholas Ave, 2Nd Floor
New York, NY 10032
(212) 851-5494
fax (212) 851-5493
Credentials & registration
- NPI registered
- September 2008 — 18 yrs on file
- Profile last updated
- August 22, 2018
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #242824-1
- Medicaid
- NY #03349584
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922257773. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
163
Distinct HCPCS
5
Medicare allowed
$11,317
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 48 | 30 | $145 | |
83036 |
Hemoglobin a1c level | 36 | 23 | $10 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 34 | 15 | $90 | |
82947 |
Blood glucose (sugar) level | 23 | 13 | $4 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | 11 | $39 |
In context: peer comparison
Among 92 peers in this city , average services per provider: 220. This provider delivers 0.7× the peer median.Open Payments
Industry payments received
All-time total
$1,453
Transactions
3
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 3 | $1,453.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
347
Patients
13
Total drug cost
$287,668
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 61 | 0 | $103,076 |
| Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) | Brand | 50 | 13 | $26,023 |
| Metformin Hcl | Generic | 34 | 0 | $570 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 26 | 0 | $31,164 |
| Novolog Flexpen (Insulin Aspart) | Brand | 24 | 0 | $21,164 |
| Novolog (Insulin Aspart) | Brand | 21 | 0 | $38,681 |
| Single Use Swab (Alcohol Antiseptic Pads) | Brand | 18 | 0 | $53 |
| Ozempic (Semaglutide) | Brand | 17 | 0 | $21,235 |
| Jardiance (Empagliflozin) | Brand | 16 | 0 | $26,672 |
| Gvoke Hypopen 2-Pack (Glucagon) | Brand | 14 | 0 | $9,262 |
Frequently asked questions
What is Dr. Utpal Pajvani's medical specialty?
Dr. Utpal Pajvani practices Endocrinology, Diabetes & Metabolism Physician in New York, NY.
Where does Dr. Utpal Pajvani practice?
Dr. Utpal Pajvani practices at 1150 Saint Nicholas Ave, New York, NY 10032. Office phone: 2128515494.
What is Dr. Utpal Pajvani's NPI?
Dr. Utpal Pajvani's National Provider Identifier (NPI) is 1922257773, issued by NPPES.
Does Dr. Utpal Pajvani accept Medicare assignment?
Yes. Dr. Utpal Pajvani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Utpal Pajvani commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.